Literature DB >> 29479654

Pemphigus group: overview, epidemiology, mortality, and comorbidities.

Khalaf Kridin1.   

Abstract

Pemphigus forms a group of rare autoimmune bullous diseases that affect the skin and mucous membranes. This group has a chronic course leading to high morbidity and mortality. It is characterized by the production of pathogenic autoantibodies directed against different proteins of the desmosome, leading histologically to intraepidermal cleavage, and clinically to vesicles and erosions on the epithelium of the mucous membranes and/or the skin. The diagnosis of the subtype of pemphigus is based on clinical features, the level of histologic cleavage, and the identification of the antigens recognized by circulating autoantibodies by immunoserological analyses. The epidemiological features of pemphigus vary considerably in different regions of the world. Observational studies examining comorbidities and associations among patients with pemphigus are scarce and sometimes inconclusive. The prognosis, mortality, and clinical outcomes in pemphigus have undergone dramatic change throughout the years. This review provides a brief overview about the different subtypes of pemphigus: pemphigus vulgaris, pemphigus foliaceus, paraneoplastic pemphigus, pemphigus herpetiformis, and IgA pemphigus. In addition, it summarizes the most recent understanding of the epidemiology, mortality data, and comorbidities of this group of organ-specific autoimmune diseases.

Entities:  

Keywords:  Associations; Comorbidities; Epidemiology; IgA pemphigus; Mortality; Paraneoplastic pemphigus; Pemphigus; Pemphigus foliaceus; Pemphigus herpetiformis; Pemphigus vulgaris

Mesh:

Substances:

Year:  2018        PMID: 29479654     DOI: 10.1007/s12026-018-8986-7

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  162 in total

1.  Herpetiform pemphigus, a variable pattern of pemphigus.

Authors:  S Jablonska; T P Chorzelski; E H Beutner; J Chorzelska
Journal:  Int J Dermatol       Date:  1975-06       Impact factor: 2.736

2.  Pemphigus group (vulgaris, vegetans, foliaceus, herpetiformis, brasiliensis).

Authors:  Pascal Joly; Noémie Litrowski
Journal:  Clin Dermatol       Date:  2011 Jul-Aug       Impact factor: 3.541

3.  Management of a pemphigus with IgA and IgG antibodies and coexistent lung cancer.

Authors:  Petra Cetkovská; Michaela Komorousová; Iva Lomicová
Journal:  Dermatol Ther       Date:  2014-04-22       Impact factor: 2.851

4.  Pemphigus Vulgaris and Pemphigus Foliaceus: Differences in Epidemiology and Mortality.

Authors:  Khalaf Kridin; Shira Zelber-Sagi; Reuven Bergman
Journal:  Acta Derm Venereol       Date:  2017-10-02       Impact factor: 4.437

Review 5.  Autoreactive T cells in the immune pathogenesis of pemphigus vulgaris.

Authors:  Kyle T Amber; Patrick Staropoli; Michael I Shiman; George W Elgart; Michael Hertl
Journal:  Exp Dermatol       Date:  2013-11       Impact factor: 3.960

6.  A blistering response: concurrent psoriasis and pemphigus foliaceus.

Authors:  Drew J B Kurtzman; Michael Christopher; Fangru Lian; James E Sligh
Journal:  Am J Med       Date:  2014-09-16       Impact factor: 4.965

Review 7.  Clinical and immunopathological spectrum of paraneoplastic pemphigus.

Authors:  Jutta Zimmermann; Friedrich Bahmer; Christian Rose; Detlef Zillikens; Enno Schmidt
Journal:  J Dtsch Dermatol Ges       Date:  2010-02-18       Impact factor: 5.584

8.  Incidence, mortality, and causes of death of patients with pemphigus in Taiwan: a nationwide population-based study.

Authors:  Yu-Huei Huang; Chang-Fu Kuo; Yi-Hua Chen; Ya-Wen Yang
Journal:  J Invest Dermatol       Date:  2011-08-18       Impact factor: 8.551

9.  Pemphigus and osteoporosis: a case-control study.

Authors:  Yonit Wohl; Jacob Dreiher; Arnon D Cohen
Journal:  Arch Dermatol       Date:  2010-10

10.  Hospitalization, inpatient burden and comorbidities associated with bullous pemphigoid in the U.S.A.

Authors:  Z Ren; D Y Hsu; J Brieva; N B Silverberg; S M Langan; J I Silverberg
Journal:  Br J Dermatol       Date:  2016-10-29       Impact factor: 9.302

View more
  41 in total

1.  A Case of Severe Refractory Pemphigus Vulgaris in a Patient With Stable Esophageal Malignancy.

Authors:  Vanessa C Browne; Catherine Choi; Eugenio M Capitle; Reena Khianey
Journal:  Cureus       Date:  2021-04-20

2.  [59/f with oral and nasal mucosal erosions : Preparation for the specialist examination: part 18].

Authors:  Mareike Witte; Detlef Zillikens
Journal:  Hautarzt       Date:  2018-11       Impact factor: 0.751

3.  Oesophageal pemphigoid: a rare cause of dysphagia.

Authors:  Michael McFarlane; Ayesha Azam; David Snead; Ben Disney
Journal:  Clin J Gastroenterol       Date:  2018-08-23

Review 4.  Targeted Therapies for Autoimmune Bullous Diseases: Current Status.

Authors:  Kyle T Amber; Roberto Maglie; Farzan Solimani; Rüdiger Eming; Michael Hertl
Journal:  Drugs       Date:  2018-10       Impact factor: 9.546

Review 5.  Genetics and Omics Analysis of Autoimmune Skin Blistering Diseases.

Authors:  Michael Olbrich; Axel Künstner; Mareike Witte; Hauke Busch; Anke Fähnrich
Journal:  Front Immunol       Date:  2019-10-15       Impact factor: 7.561

6.  Assessment of Immune Cell Activation in Pemphigus.

Authors:  Anna Kowalska-Kępczyńska; Mateusz Mleczko; Weronika Domerecka; Dorota Krasowska; Helena Donica
Journal:  Cells       Date:  2022-06-13       Impact factor: 7.666

Review 7.  Serological Biomarkers and Their Detection in Autoimmune Bullous Skin Diseases.

Authors:  Ilana Heckler; Michael Hong; Animesh Amart Sinha; Iswariya Venkataraman
Journal:  Dermatol Pract Concept       Date:  2022-04-01

8.  Use of minocycline for the treatment of prurigo pigmentosa with intraepidermal vesiculation: a case report.

Authors:  Jie Yang; Shicheng Jiao; Min Zhang
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

9.  Illness Perception, Perceived Social Support and Quality of Life in Patients with Pemphigus Vulgaris: What Should Dermatologists Know?

Authors:  Oz Segal; Gil Goldzweig; Einat Tako; Aviv Barzilai; Anna Lyakhovitsky; Sharon Baum
Journal:  Acta Derm Venereol       Date:  2021-04-27       Impact factor: 3.875

Review 10.  Bullous Autoimmune Dermatoses–Clinical Features, Diagnostic Evaluation, and Treatment Options.

Authors:  Nina van Beek; Detlef Zillikens; Enno Schmidt
Journal:  Dtsch Arztebl Int       Date:  2021-06-18       Impact factor: 8.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.